Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Childhood
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower Term)
    Reference: '202300'
    Source: OMIM
  Genes:
  - Gene:
      ExternalReferences: []
      Name: tumor protein p53
      Symbol: TP53
  Label: Adrenocortical carcinoma
  ORPHAcode: '1501'
  ORPHApacketId: '1501'
  PURL: http://www.orpha.net/ORDO/Orphanet_1501
  Parents:
  - Parent:
    - Label: Adrenal/paraganglial tumor
      ORPHAcode: '100091'
  - Parent:
    - Label: ACTH-independent Cushing syndrome due to rare cortisol-producing adrenal
        tumor
      ORPHAcode: '443287'
  - Parent:
    - Label: Pediatric adrenal/paraganglial cancer
      ORPHAcode: '602709'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Obligate (100%)
      HPOId: HP:0006744
      HPOTerm: Adrenocortical carcinoma
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000080
      HPOTerm: Abnormality of reproductive system physiology
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000737
      HPOTerm: Irritability
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000739
      HPOTerm: Anxiety
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000819
      HPOTerm: Diabetes mellitus
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000822
      HPOTerm: Hypertension
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000859
      HPOTerm: Hyperaldosteronism
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000975
      HPOTerm: Hyperhidrosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000998
      HPOTerm: Hypertrichosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001065
      HPOTerm: Striae distensae
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001324
      HPOTerm: Muscle weakness
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001824
      HPOTerm: Weight loss
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001939
      HPOTerm: Abnormality of metabolism/homeostasis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001962
      HPOTerm: Palpitations
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002027
      HPOTerm: Abdominal pain
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002900
      HPOTerm: Hypokalemia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003118
      HPOTerm: Increased circulating cortisol level
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003466
      HPOTerm: Paradoxical increased cortisol secretion on dexamethasone suppression
        test
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0004324
      HPOTerm: Increased body weight
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0011748
      HPOTerm: Adrenocorticotropic hormone deficiency
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012030
      HPOTerm: Increased urinary cortisol level
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0025134
      HPOTerm: Increased serum estradiol
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0025269
      HPOTerm: Panic attack
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0025380
      HPOTerm: Increased serum androstenedione
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0025436
      HPOTerm: Elevated serum 11-deoxycortisol
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030078
      HPOTerm: Lung adenocarcinoma
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030348
      HPOTerm: Increased circulating androgen level
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0500022
      HPOTerm: Abnormal serum dehydroepiandrosterone level
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003110
      HPOTerm: Abnormality of urine homeostasis
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: European Medicines Agency[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22796286[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Malta
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  TextSection:
    Contents: A rare cancer that arises from the adrenal cortex.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
  copyright: Orphanet (c) 2022
  creationDate: '2022-06-14 15:58:09'
  version: 1.3.16 / 4.1.7 [2022-01-26] (orientdb version)
